临床试验

C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.

NCT：NCT03311451 · ACTIVE_NOT_RECRUITING

NCT编号NCT03311451

状态ACTIVE_NOT_RECRUITING

开始日期2023-01-16

完成时间2026-12-18

SponsorMerit Medical Systems, Inc. (INDUSTRY)

First posted2017-10-17

Last updated2026-05-22

简要摘要

The primary objective is to determine the safety and efficacy of the C2 CryoBalloon 180 Ablation System ("CryoBalloon 180") used at decreasing doses in ablation naïve patients with low- or high-grade dysplastic Barrett's Esophagus (BE) or with residual BE after resection of dysplasia or early adenocarcinoma.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。